Category

UF Innovate | Tech Licensing

Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030

UF Startup Kate Therapeutics, a gene therapy specialist, is being acquired by Novartis in a deal worth up to $1.1 billion. This acquisition aligns with Novartis’s efforts to deliver treatments for neuromuscular disorders and fits into the pharma’s strategy to expand its new modality pipeline, ensuring long-term business sustainability.

Diabetes Detectives

University of Florida aims to improve the lives of millions with diabetes through its clinical and research programs and is globally recognized for its efforts.

UF Health Study To Assess Pharmacogenetic Testing in the ER

UF researchers spanning the Gainesville and Jacksonville campuses launched a five-year research project measuring the feasibility, cost-effectiveness, and net benefits of implementing precision medicine strategies like pharmacogenetic testing in the emergency room.